Press Releases

The global CRISPR gene editing market is mainly driven by the significant growth of CRISPR as it offers precision in editing and cite-specific modifications and is projected to have a CAGR of 28.60%  during the forecast period 2025-2030. The great efficiency of the CRISPR-Cas9 system for genome editing has been established in a number of studies, resulting in considerable investments in the field of genome engineering. The global CRISPR gene editing market is being driven by rising incidences of genetic disorders, continuous substantial investments by healthcare businesses to meet industry demand, and the growing significance of gene therapy treatments with shorter turnaround times along with the mounting demand from the food industry to offer better quality products having proper nutrient. However, while there are several benefits, there are also drawbacks that must be considered prior to clinical implementation. In addition, numerous experts are striving to improve the limits of CRISPR gene-editing technology. CRISPR gene editing has the ability to alter the human genome and adjust disease conditions, but it is fraught with ethical and social issues.

In October 2021, Merck, a prominent scientific and technology corporation, announced that Cellecta, Inc., a functional genomics products and services provider based in Mountain View, California, has inked an agreement licensing its proprietary CRISPR-Cas9 technology. Merck is paving the way for researchers and scientists to uncover and accelerate next-generation treatments for inherited blood disorders, cancers, and ophthalmological diseases, among others by licensing its revolutionary technologies.

Browse 53 market data Tables and 35 Figures spread through 200 Pages and in-depth TOC on " CRISPR Gene Editing Market by Product Type (CRISPR Products  (Kits & Enzymes, Libraries, Design Tools, Antibodies, and Others) and CRISPR Services (gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, and Others), by Application (Agriculture, Biomedical, Industrial, and Others), by End User (Academic Institutes and Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), and Pharmaceutical and Biopharmaceutical Companies), and Region - Global Forecast to 2030"

By application, the biomedical application will dominate the market during the forecast period.

The biomedical application holds the largest share in the CRISPR gene editing market owing to increased adoption in drug discovery applications so as to create more physiologically appropriate models (cell lines and animal models) that correspond better with the clinical situation, reducing drug candidate failed in the early stages.

Global CRISPR Gene Editing Market Segmentation and Key Players

Discover More About This Report, Download A Free Sample Copy of Global CRISPR Gene Editing Market

“Asia-Pacific is expected to have a high CAGR during 2025-2030.”

Asia-Pacific is anticipated to have a high CAGR during the forecast period owing to rising funding, support by the government to the public and private research, and academic institutes to focus on R&D activities.

Some of the major players in the global CRISPR Gene Editing market include Merck KGaA, Thermo Fisher Scientific Inc., Applied StemCell, Abcam plc, CRISPR Therapeutics, Cellecta, Inc., GenScript, ToolGen, Inc., Takara Bio Inc., and OriGene Technologies, Inc.

Global CRISPR Gene Editing Market Coverage

Product Type Insight and Forecast 2025-2030

• CRISPR Products 
  • Kits & Enzymes
  • Libraries
  • Design Tools
  • Antibodies
  • Others
• CRISPR Services
  • gRNA Design and Vector Construction
  • Cell Line and Engineering
  • Screening Services
  • Others

Application Insight and Forecast 2025-2030

• Agriculture
• Biomedical
• Industrial
• Others

End User Insight and Forecast 2025-2030

• Academic Institutes and Research Centers
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Pharmaceutical and Biopharmaceutical Companies

Geographical Segmentation

CRISPR Gene Editing Market by Region

North America

• By Product Type
• By Application
• By End User
• By Deployment Mode
• By Organization Size
• By Vertical
• By Country – U.S., Canada, and Mexico

Europe

• By Product Type
• By Application
• By End User
• By Deployment Mode
• By Organization Size
• By Vertical
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Product Type
• By Application
• By End User
• By Deployment Mode
• By Organization Size
• By Vertical
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Product Type
• By Application
• By End User
• By Deployment Mode
• By Organization Size
• By Vertical
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries